Vestal Point Capital, LP
Q4 2024 13F Holdings
- Locationnew york, NY
- Num holdings
73
- Value ($000)
$1,686,706
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001974915
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLC | SHS USD | G50871105 | $120.07M | 7 % | 975,000 | ||
CYTK Cytokinetics Inc | COM NEW | 23282W605 | $110.54M | 7 % | 2,350,000 | ||
MRK Merck & Co Inc | COM | 58933Y105 | $79.58M | 5 % | 800,000 | ||
ASND Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | $71.59M | 4 % | 520,000 | ||
RARE Ultragenyx Pharmaceutical Inc | COM | 90400D108 | $63.10M | 4 % | 1,500,000 | ||
INSM Insmed Inc | COM PAR $.01 | 457669307 | $62.14M | 4 % | 900,000 | ||
BMRN BioMarin Pharmaceutical Inc | COM | 09061G101 | $56.53M | 3 % | 860,000 | ||
uniQure NV | SHS | N90064101 | $53.42M | 3 % | 3,025,000 | ||
Soleno Therapeutics Inc | COM | 834203309 | $47.65M | 3 % | 1,060,000 | ||
NUVL Nuvalent Inc | COM | 670703107 | $46.97M | 3 % | 600,000 |
Rows Per Page
1 - 10 of 7310
- 10
- 50
- 100